GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shattuck Labs Inc (NAS:STTK) » Definitions » Piotroski F-Score

Shattuck Labs (Shattuck Labs) Piotroski F-Score : 2 (As of Jun. 05, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shattuck Labs Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shattuck Labs has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Shattuck Labs's Piotroski F-Score or its related term are showing as below:

STTK' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 2   Max: 3
Current: 2

During the past 6 years, the highest Piotroski F-Score of Shattuck Labs was 3. The lowest was 1. And the median was 2.


Shattuck Labs Piotroski F-Score Historical Data

The historical data trend for Shattuck Labs's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shattuck Labs Piotroski F-Score Chart

Shattuck Labs Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial N/A N/A 2.00 1.00 3.00

Shattuck Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 1.00 1.00 3.00 2.00

Competitive Comparison of Shattuck Labs's Piotroski F-Score

For the Biotechnology subindustry, Shattuck Labs's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shattuck Labs's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shattuck Labs's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Shattuck Labs's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was -21.346 + -27.541 + -17.687 + -18.504 = $-85.08 Mil.
Cash Flow from Operations was -18.616 + -16.732 + -19.419 + -16.161 = $-70.93 Mil.
Revenue was 0.2 + 0.686 + 0.714 + 1.115 = $2.72 Mil.
Gross Profit was 0.2 + 0.686 + 0.714 + 1.115 = $2.72 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(177.677 + 155.27 + 130.457 + 159.564 + 146.335) / 5 = $153.8606 Mil.
Total Assets at the begining of this year (Mar23) was $177.68 Mil.
Long-Term Debt & Capital Lease Obligation was $3.19 Mil.
Total Current Assets was $131.08 Mil.
Total Current Liabilities was $14.33 Mil.
Net Income was -27.371 + -24.635 + -25.411 + -20.724 = $-98.14 Mil.

Revenue was 0.05 + 0.212 + 0.39 + 0.057 = $0.71 Mil.
Gross Profit was 0.05 + 0.212 + 0.39 + 0.057 = $0.71 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(270.49 + 251.34 + 222.943 + 205.324 + 177.677) / 5 = $225.5548 Mil.
Total Assets at the begining of last year (Mar22) was $270.49 Mil.
Long-Term Debt & Capital Lease Obligation was $4.01 Mil.
Total Current Assets was $157.84 Mil.
Total Current Liabilities was $16.01 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shattuck Labs's current Net Income (TTM) was -85.08. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shattuck Labs's current Cash Flow from Operations (TTM) was -70.93. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=-85.078/177.677
=-0.47883519

ROA (Last Year)=Net Income/Total Assets (Mar22)
=-98.141/270.49
=-0.36282672

Shattuck Labs's return on assets of this year was -0.47883519. Shattuck Labs's return on assets of last year was -0.36282672. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Shattuck Labs's current Net Income (TTM) was -85.08. Shattuck Labs's current Cash Flow from Operations (TTM) was -70.93. ==> -70.93 > -85.08 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=3.193/153.8606
=0.02075255

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=4.014/225.5548
=0.01779612

Shattuck Labs's gearing of this year was 0.02075255. Shattuck Labs's gearing of last year was 0.01779612. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=131.076/14.329
=9.14760276

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=157.837/16.009
=9.85926666

Shattuck Labs's current ratio of this year was 9.14760276. Shattuck Labs's current ratio of last year was 9.85926666. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Shattuck Labs's number of shares in issue this year was 50.566. Shattuck Labs's number of shares in issue last year was 42.439. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=2.715/2.715
=1

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.709/0.709
=1

Shattuck Labs's gross margin of this year was 1. Shattuck Labs's gross margin of last year was 1. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=2.715/177.677
=0.01528054

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=0.709/270.49
=0.00262117

Shattuck Labs's asset turnover of this year was 0.01528054. Shattuck Labs's asset turnover of last year was 0.00262117. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+0+1
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shattuck Labs has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Shattuck Labs  (NAS:STTK) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Shattuck Labs Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Shattuck Labs's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Shattuck Labs (Shattuck Labs) Business Description

Traded in Other Exchanges
N/A
Address
500 W. 5th Street, Suite 1200, Austin, TX, USA, 78701
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
Executives
Andrew R Neill officer: See Remarks 1018 W 11TH STREET, SUITE 100, AUSTIN TX 78703
Stephen Stout officer: See Remarks C/O SHATTUCK LABS, INC., 500 W. 5TH STREET, SUITE 1200, AUSTIN TX 78701
George Golumbeski director C/O CELGENE CORP., 86 MORRIS AVENUE, SUMMIT NJ 07901
Abhinav A. Shukla officer: Chief Technical Officer 500 W. 5TH STREET, SUITE 1200, AUSTIN TX 78701
Carrie Brownstein director 500 W. 5TH ST., SUITE 1200, AUSTIN TX 78701
Erin Ator Thomson officer: General Counsel 1018 W 11TH ST., SUITE 100, AUSTIN TX 78703
Josiah Hornblower director, 10 percent owner, officer: Chairman 3317 BOWMAN AVE, AUSTIN TX 78703
Taylor Schreiber director, officer: Chief Executive Officer 100 EUROPA DRIVE, CHAPEL HILL NC 27517
Redmile Group, Llc director, 10 percent owner ONE LETTERMAN DRIVE, BUILDING D, SUITE D3-300, SAN FRANCISCO CA 94129
Helen M Boudreau director 200 TECHNOLOGY SQUARE, 4TH FLOOR, CAMBRIDGE MA 02139
Neil W Gibson director C/O REGULUS THERAPEUTICS INC., 3545 JOHN HOPKINS COURT SUITE 210, SAN DIEGO CA 92121
Tyler Brous director 1018 W 11TH ST., SUITE 100, AUSTIN TX 78703
Casi Deyoung officer: Chief Business Officer C/O MIRNA THERAPEUTICS, INC., 2150 WOODWARD ST., SUITE 100, AUSTIN TX 78744
Arundathy N. Pandite officer: Chief Medical Officer 1018 W 11TH ST., SUITE 100, AUSTIN TX 78703
Victor Stone director 1018 W 11TH ST., SUITE 100, AUSTIN TX 78703

Shattuck Labs (Shattuck Labs) Headlines

From GuruFocus

Shattuck Labs Announces Participation in Upcoming March Conferences

By sperokesalga sperokesalga 03-01-2023